- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07505251
Development and Validation of the Periodontal Map Derived From IOS and CBCT Registration for Diagnosis and Treatment Planning in Moderate-to-severe Periodontitis
March 26, 2026 updated by: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
This prospective diagnostic study aims to validate the clinical utility of a "Periodontal Panoramic Map" generated by the PerioAI V2.0 system, an artificial intelligence-based platform that integrates intraoral scans and cone-beam CT data, for preoperative diagnosis and surgical planning in patients with moderate to severe periodontitis (Stage II-IV).
Current clinical standards-manual probing and two-dimensional radiography-have inherent limitations in accurately visualizing complex three-dimensional bone defect morphology, leading to potential underestimation of disease severity and suboptimal surgical outcomes.
Building upon our team's previously published high-precision PerioAI V1.0 system, this study will enroll 80 patients requiring periodontal surgery.
Preoperative intraoral scans and cone-beam CT images will be acquired as part of routine care, and the PerioAI V2.0 system will automatically generate a "Periodontal Panoramic Map" with intelligent outputs including probing depth, clinical attachment loss, bone defect morphology classification, furcation involvement grading, and automated measurements of key parameters such as intra-bony defect depth and width.
These automated diagnostic results will be compared against the gold standard of full mouth clinical examination and intra-operative direct measurements and observations obtained during periodontal surgery under strict blinded conditions.
The primary outcome measures are the accuracy of bone defect morphology classification and the agreement between automated and intra-operative linear measurements assessed by intraclass correlation coefficients and Bland-Altman analysis.
Secondary outcomes include accuracy of probing depth, clinical attachment loss, periodontitis staging and grading, furcation involvement grading and treatment planning.
This study will provide critical evidence supporting the paradigm shift in periodontal surgery from experience-dependent assessment to data-driven precision medicine, ultimately offering clinicians an intuitive, quantitative, and three-dimensional visualization tool for optimized surgical decision-making.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yuan Li, Dr.
- Phone Number: 13916337473
- Email: ly9919@hotmail.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patient diagnosed with Stage II-IV periodontitis and has at least one tooth requiring periodontal surgery
Description
Inclusion Criteria:
- Aged ≥ 18 years.
- Diagnosed with Stage II-IV periodontitis according to the 2018 Classification of Periodontal Diseases.
- Presence of at least one tooth requiring periodontal surgery (including open flap debridement or regenerative surgery) due to periodontitis, where the intra-bony defect can be exposed intra-operatively for measurement.
- Voluntary participation and provision of written informed consent.
Exclusion Criteria:
- Pregnant or lactating women.
- Presence of uncontrolled systemic diseases that significantly affect surgery or tissue healing, such as uncontrolled diabetes mellitus or immunodeficiency.
- History of head and neck radiotherapy.
- Inability to cooperate with the required study examinations.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Periodontitis Surgical Cohort
|
This is a single-arm, prospective diagnostic accuracy study.
The intervention is the application of an artificial intelligence-based software (PerioAI V2.0) to routinely acquired preoperative intra-oral scan and cone-beam CT data.
The software generates a "Periodontal Panoramic Map" with automated measurements and classifications.
All participants then undergo routine full clinical examination and clinically indicated periodontal surgery, which are obtained as the gold standard to validate the accuracy of the Perio AI V2.0 system's preoperative diagnostic outputs.
The study does not involve any experimental therapeutic interventions; all surgical procedures are part of standard care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of Bone Defect Morphology Classification by PerioAI System Compared to Intraoperative Findings
Time Frame: Preoperative (PerioAI system analysis) and intraoperative (direct surgical observation)
|
The PerioAI 2.0 system automatically classifies bone defect morphology (1-wall, 2-wall, 3-wall intrabony defects, dehiscence, or fenestration) based on preoperative intraoral scan and cone-beam CT data.
The classification accuracy is assessed by comparing the PerioAI-generated classification against the gold standard of intraoperative direct visual observation by an experienced surgeon during periodontal surgery.
Results are reported as the percentage of correctly classified defects (accuracy rate), with sensitivity and specificity for each defect type.
|
Preoperative (PerioAI system analysis) and intraoperative (direct surgical observation)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Agreement Between PerioAI-Automated Probing Depth Measurements and Clinical Probing Depth
Time Frame: Preoperative (PerioAI system analysis and clinical examination)
|
Probing depth (PD) is measured in millimeters at six sites per tooth (mesio-buccal, mid-buccal, disto-buccal; mesio-lingual, mid-lingual, disto-lingual).
The PerioAI system automatically measures PD from fused intraoral scan and cone-beam CT data.
These automated measurements are compared with clinical PD measurements obtained by a trained periodontist using a manual periodontal probe (UNC-15).
Agreement is assessed using intraclass correlation coefficients and Bland-Altman analysis.
|
Preoperative (PerioAI system analysis and clinical examination)
|
|
Agreement Between PerioAI-Automated Clinical Attachment Loss Measurements and Clinical Attachment Loss
Time Frame: Preoperative (PerioAI system analysis and clinical examination)
|
Clinical attachment loss (CAL) is measured in millimeters as the distance from the cementoenamel junction to the base of the pocket at six sites per tooth.
The PerioAI system automatically measures CAL from fused intraoral scan and cone-beam CT data.
These automated measurements are compared with clinical CAL measurements obtained by a trained periodontist using a manual periodontal probe (UNC-15).
Agreement is assessed using intraclass correlation coefficients and Bland-Altman analysis.
|
Preoperative (PerioAI system analysis and clinical examination)
|
|
Agreement Between PerioAI-Automated Periodontitis Staging and Grading and Clinical Staging and Grading
Time Frame: Preoperative (PerioAI system analysis and clinical examination)
|
Periodontitis stage (II, III, or IV) and grade (A, B, or C) are determined according to the 2018 Classification of Periodontal Diseases.
The PerioAI system automatically assigns stage and grade based on analysis of intraoral scan and cone-beam CT data (including radiographic bone loss, tooth loss, defect complexity, and other parameters).
These automated classifications are compared with clinical staging and grading performed by a trained periodontist using full-mouth periodontal charting, radiographic review, and the 2018 classification criteria.
Agreement is assessed using weighted kappa statistics.
|
Preoperative (PerioAI system analysis and clinical examination)
|
|
Accuracy of Furcation Involvement Grading by PerioAI System Compared to Intraoperative Findings
Time Frame: Preoperative (PerioAI system analysis) and intraoperative (direct surgical exploration)
|
Furcation involvement is graded as Grade I, II, or III according to the 2018 Classification of Periodontal Diseases.
The PerioAI system automatically assigns furcation involvement grade based on cone-beam CT data.
The accuracy of the PerioAI-generated grading is assessed by comparing it against the gold standard of intraoperative direct exploration using a Nabers probe during periodontal surgery.
Results are reported as the percentage of correctly graded furcations (accuracy rate), with sensitivity and specificity for each grade.
|
Preoperative (PerioAI system analysis) and intraoperative (direct surgical exploration)
|
|
Agreement Between PerioAI-Automated Intrabony Defect Depth Measurements and Intraoperative Direct Measurements
Time Frame: Preoperative (PerioAI system analysis) and intraoperative (direct surgical measurement)
|
Intrabony defect depth (INTRA) is measured in millimeters from the alveolar crest to the base of the defect.
The PerioAI system automatically measures INTRA from fused intraoral scan and cone-beam CT data.
These automated measurements are compared with direct intraoperative measurements obtained by an experienced surgeon using a periodontal probe after flap elevation.
Agreement is assessed using intraclass correlation coefficients and Bland-Altman analysis.
|
Preoperative (PerioAI system analysis) and intraoperative (direct surgical measurement)
|
|
Agreement Between PerioAI-Automated Intrabony Defect Width Measurements and Intraoperative Direct Measurements
Time Frame: Preoperative (PerioAI system analysis) and intraoperative (direct surgical measurement)
|
Intrabony defect width (WIDTH) is measured in millimeters from the root surface to the most coronal part of the bony defect.
The PerioAI system automatically measures WIDTH from fused intraoral scan and cone-beam CT data.
These automated measurements are compared with direct intraoperative measurements obtained by an experienced surgeon using a periodontal probe after flap elevation.
Agreement is assessed using intraclass correlation coefficients and Bland-Altman analysis.
|
Preoperative (PerioAI system analysis) and intraoperative (direct surgical measurement)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2026
Primary Completion (Estimated)
April 30, 2028
Study Completion (Estimated)
December 31, 2028
Study Registration Dates
First Submitted
March 18, 2026
First Submitted That Met QC Criteria
March 26, 2026
First Posted (Actual)
April 1, 2026
Study Record Updates
Last Update Posted (Actual)
April 1, 2026
Last Update Submitted That Met QC Criteria
March 26, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SH9H-2026-T98-1
- JYLJ2025015 (Other Grant/Funding Number: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periodontitis Stage II
-
Misr University for Science and TechnologyCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Cairo UniversityRecruitingPeriodontitis | Periodontitis Stage II | Periodontitis Stage IIIEgypt
-
Ataturk UniversityCompletedPeriodontitis | Periodontitis Stage I | Periodontitis Stage IITurkey (Türkiye)
-
Cairo UniversityNot yet recruitingStage II or Stage III Grade B PeriodontitisEgypt
-
Al-Azhar UniversityEnrolling by invitationPeriodontitis Stage IIEgypt
-
The University of Hong KongDentaid SLNot yet recruitingPeriodontitis | Periodontitis Stage II | Periodontitis Stage III
-
Mansoura UniversityCompletedPeriodontitis | Periodontal Disease | Periodontitis Stage IIEgypt
-
Mahsa UniversityRecruitingPeriodontitis | Periodontitis Chronic Generalized Moderate | Periodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Chronic Generalized Severe | Periodontitis, Chronic | Periodontitis Stage II | Periodontitis Chronic Localized Slight | Periodontitis Stage IIIMalaysia
-
Suez Canal UniversityCompleted
-
Kafrelsheikh UniversityEnrolling by invitationPeriodontitis Stage IIEgypt
Clinical Trials on Perio AI V2.0 System
-
Tsinghua UniversityNot yet recruiting
-
Magic Health Inc. (d.b.a. Nolla Health)RecruitingDifferential Diagnosis | Diagnostic AccuracyUnited States
-
The Third Xiangya Hospital of Central South UniversityRecruitingMediastinum DiseaseChina
-
Qun ZhaoCompletedGastrointestinal Stromal Tumors | Gastric Subepithelial Tumors | Artificial Intelligence (AI) | Gastric Leiomyoma | Multimodal ImagingChina
-
The Hong Kong Polytechnic UniversityNot yet recruitingRetinal Disease | Eye Disease | Ophthalmology | AI Agent | Large Language ModelsChina
-
Qilu Hospital of Shandong UniversityThe Affiliated Hospital of Qingdao University; Shandong Provincial Hospital; Liaocheng... and other collaboratorsRecruitingThe Malignant Lesions and Non-malignant Lesions of Pancreas, Bile Duct, Liver and Lymph NodeChina
-
Centre hospitalier de l'Université de Montréal...Roupen Djinbachian, MD; Mahsa Taghiakbari, MD PHDNot yet recruitingColonic Polyp | Artificial IntelligenceCanada
-
Renmin Hospital of Wuhan UniversityNot yet recruitingArtificial Intelligence | Endoscopy, Gastrointestinal
-
Chinese PLA General HospitalUnknownBleeding | Acute Coronary Syndrome | Percutaneous Coronary InterventionChina